Growth Metrics

Envoy Medical (COCH) Depreciation & Amortization (CF) (2022 - 2026)

Envoy Medical's Depreciation & Amortization (CF) history spans 5 years, with the latest figure at $73000.0 for Q1 2026.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 19.67% to $73000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was $329000.0, a 27.52% increase, with the full-year FY2025 number at $302000.0, up 74.57% from a year prior.
  • Depreciation & Amortization (CF) hit $73000.0 in Q1 2026 for Envoy Medical, down from $80000.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for COCH hit a ceiling of $100000.0 in Q2 2024 and a floor of $15000.0 in Q4 2023.
  • Historically, Depreciation & Amortization (CF) has averaged $53357.1 across 5 years, with a median of $48500.0 in 2024.
  • Biggest five-year swings in Depreciation & Amortization (CF): plummeted 42.31% in 2023 and later surged 244.83% in 2024.
  • Tracing COCH's Depreciation & Amortization (CF) over 5 years: stood at $26000.0 in 2022, then plummeted by 42.31% to $15000.0 in 2023, then soared by 220.0% to $48000.0 in 2024, then surged by 66.67% to $80000.0 in 2025, then dropped by 8.75% to $73000.0 in 2026.
  • Business Quant data shows Depreciation & Amortization (CF) for COCH at $73000.0 in Q1 2026, $80000.0 in Q4 2025, and $76000.0 in Q3 2025.